WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (145)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dworetzky, S. I.
Right arrow Articles by Gribkoff, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dworetzky, S. I.
Right arrow Articles by Gribkoff, V. K.

 Previous Article  |  Next Article 

Volume 16, Number 15, Issue of August 1, 1996 pp. 4543-4550
Copyright ©1996 Society for Neuroscience

Phenotypic Alteration of a Human BK (hSlo) Channel by hSlobeta Subunit Coexpression: Changes in Blocker Sensitivity, Activation/Relaxation and Inactivation Kinetics, and Protein Kinase A Modulation

Steven I. Dworetzky, Christopher G. Boissard, Janet T. Lum-Ragan, M. Craig McKay, Debra J. Post-Munson, Joanne T. Trojnacki, Chia-Ping Chang, and Valentin K. Gribkoff

Central Nervous System Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

A human homolog of the large-conductance calcium-activated potassium (BK) channel beta  subunit (hSlobeta ) was cloned, and its effects on a human BK channel (hSlo) phenotype are reported. Coexpression of hSlo and hSlobeta , in both oocytes and human embryonic kidney 293 cells, resulted in increased Ca2+ sensitivity, marked slowing of BK channel activation and relaxation, and a significant reduction in slow inactivation. In addition, coexpression changed the pharmacology of the BK channel phenotype: hSlo-mediated currents in oocytes were more sensitive to the peptide toxin iberiotoxin than were hSlo + hSlobeta currents, and the potency of blockade by the alkaloid BK blocker tetrandrine was much greater on hSlo + hSlobeta -mediated currents compared with hSlo currents alone. No significant differences in the response to charybdotoxin or the BK channel opener NS1619 were observed. Modulation of BK channel activity by phosphorylation was also affected by the presence of the hSlobeta subunit. Application of cAMP-dependent protein kinase increased POPEN of hSlo channels, but decreased POPEN of most hSlo + hSlobeta channels. Taken together, these altered characteristics may explain some of the wide diversity of BK channel phenotypes observed in native tissues.

Key words: BK channels; coexpression; hSlo; modulation; channel blockers; BK phenotypes


INTRODUCTION

Potassium channels are the most diverse class of ion channels. The voltage-dependent potassium (K+) channels achieve phenotypic variation in part through the evolution of gene families coding for similar channels (Pongs, 1992; Salkoff et al., 1992; Chandy and Gutman, 1995), unlike another important class of K+ channels, the large-conductance calcium (Ca2+)-activated K+ (BK) channels (Robitaille and Charlton, 1992; Bielefeldt and Jackson, 1993). BK channels are regulated by both voltage and internal calcium concentration; these factors, together with their large single-channel conductance, make them very effective regulators of cell excitability, particularly adapted to monitoring and indirectly regulating calcium entry. BK channels have multiple phenotypes (Latorre et al., 1989; Reinhart et al., 1989; Wang and Lemos, 1992), but, to date, only one gene has been identified (Atkinson et al., 1991; Adelman et al., 1992; Butler et al., 1993; Dworetzky et al., 1994; Pallanck and Ganetzky, 1994). At least two phenotypes exist in rat brain: type I BK channels (fast-gating, BK toxin-sensitive channels activated by cAMP-dependent protein phosphorylation) and type II BK channels (relatively toxin-insensitive, slowly-gating, blocked by the alkaloid tetrandrine, with activity reduced by cAMP-dependent protein phosphorylation) (Reinhart et al., 1989, 1991; Wang and Lemos, 1992). Alternative exon splice variation confers different properties on BK channels, particularly in relation to calcium sensitivity, but this does not seem to be sufficient to account for these major phenotypic classes (Lagrutta et al., 1994; Tseng-Crank et al., 1994). Regulatory (beta ) subunits have been shown to alter rates of inactivation of voltage-dependent K+ channels (Rettig et al., 1994), and a recently cloned bovine BK channel beta  subunit (Knaus et al., 1994) was found to increase the sensitivity of cloned BK channels to Ca2+ (McCobb et al., 1995; McManus et al., 1995) and to the BK channel opener DHS-1 (McManus et al., 1995). In this study, we report the cloning of a human BK beta  subunit (hSlobeta ) and describe how coexpression alters the biophysical and pharmacological characteristics of a cloned human BK channel.

MATERIALS AND METHODS

Cloning of the human beta  subunit. PCR primers were designed adjacent to the 5' and 3' end of the bovine beta  subunit sequence (Knaus et al., 1994) and used to amplify partial clones by PCR (45 sec, 94°C; 60 sec, 45°C; 75 sec, 72°C; 35 cycles) from reverse-transcribed human tracheal poly A+ RNA. The resulting DNA fragment was isolated, purified, random-prime-labeled with deoxycytidine [alpha -32P]triphosphate, and used to screen a human uterus cDNA library (Clontech, Palo Alto, CA). The filters were hybridized in 30% formamide, 2X PIPES, and 1% SDS at 42°C, and washed in 0.1× SSC, 0.1% SDS at 42°C. Resulting positive plaques were plate-purified, and the inserts were isolated by EcoRI restriction enzyme digestion. Positive clonal inserts were ligated into pBluescriptKS+ (Stratagene, La Jolla, CA), and both strands were sequenced by dideoxy termination reactions. To remove the 5' and 3' untranslated regions of the hSlobeta clone, synthetic oligonucleotide primers were designed to amplify only the hSlobeta coding region with a T3 RNA polymerase and Kozak consensus sequence (Kozak, 1987) added to the 5' end [forward primer; 5'-CGCAATTAACCCTCACTAAAGGGCGCCACCATGGTGAAGAAGCTGGTGATGGCC-3' and reverse primer; 5'-GCATGGATGGATGTCACTACTTCTGG-3']. The hSlobeta PCR product was subcloned into the pCRII TA cloning vector (Invitrogen, San Diego, CA), sequenced to verify possible PCR amplification errors, and used for preparation of cRNA. The original hSlobeta insert was also subcloned into pcDNA3 (Invitrogen) for mammalian expression in human embryonic kidney (HEK) 293 cells. The hSlobeta clone was tested for expression by in vitro transcription and translation (not shown). The Genbank accession number for the hSlobeta clone is U38907.

Expression and recording in Xenopus oocytes. The hSlo and hSlobeta cDNAs were linearized with the restriction enzyme NotI and BamHI, respectively, and in vitro transcribed using the mMessage mMachine T3 RNA polymerase kit according to the manufacturer's instructions (Ambion, Austin, TX). The cRNAs were solubilized in RNase-free water and stored at -70°C at a concentration of 1.5 µg/µl. The hSlo construct used in the present experiments was originally cloned from a human brain substantia nigra cDNA library (Dworetzky et al., 1994) and did not contain any of the previously identified alternative splice exons (Dworetzky et al., 1994; Tseng-Crank et al., 1994). Frog oocytes were prepared and injected using standard techniques (Colman, 1984). In hSlo + hSlobeta coexpression experiments, each oocyte was injected with ~50 nl of the appropriate cRNA, resulting in total injections of 100 nl/oocyte. Injection of equivalent amounts of hSlo cRNA (50 nl) supplemented with 50 nl of RNase-free water did not alter the characteristics of hSlo currents. After injection, oocytes were maintained at 17°C in ND96 medium consisting of (in mM): 90 NaCl, 1.0 KCl, 1.0 CaCl2, 1.0 MgCl2, 5.0 HEPES, pH 7.5. Horse serum and penicillin/streptomycin, both 5% of final volume, were added as supplements to the incubation medium. Electrophysiological recording commenced 2-6 d after cRNA injection. Before the start of an experiment, oocytes were placed in a recording chamber and incubated in modified Barth's solution (MBS) consisting of (in mM): 88 NaCl, 2.4 NaHCO3, 1.0 KCl, 10 HEPES, 0.82 MgSO4, 0.33 Ca(NO3)2, 0.41 CaCl2, pH 7.5. Oocytes were impaled with electrodes (1-2 MOmega ), and standard, two-electrode voltage-clamp techniques were used to record whole-cell membrane currents (Stuhmer, 1992; GeneClamp 500, Axon Instruments, or Turbo TEC01C, Adams and List). Voltage-clamp protocols typically consisted of a series of voltage steps 100-750 msec duration in 20 mV steps from a holding potential of -60 mV to a maximal potential of 100-140 mV; records were digitized at 5 kHz and stored on a computer with pClamp 6.0 or AxoData software (Axon Instruments, Foster City, CA).

Expression and recording in HEK 293 cells. HEK 293 cells were plated on poly-D-lysine-coated coverslips at 10-20% confluency and transiently transfected 3 d later with either hSlo (1 µg DNA/35 mm dish) or hSlo + hSlobeta (0.75 µg of each DNA/35 mm dish) by the lipofectamine method according to the manufacturer's instructions (Life Technologies, Gaithersburg, MD). Whole-cell and excised patch voltage-clamp recordings were made with standard techniques (Hamill et al., 1981) 24-72 hr after transfection. An Axopatch 200 amplifier and pClamp 6.0 software (Axon Instruments) were used for all recordings. The bath solution for both whole-cell and outside-out patch recordings contained (in mM): 145 NaCl, 3 KCl, 2.5 CaCl2, 1 MgCl2, 10 HEPES, pH 7.4. The internal solution for whole-cell recordings was (in mM): 140 KCl, 20 MOPS, 0.2 K2EGTA, 0.174 CaCl2 (1 µM estimated [Ca2+]free), pH 7.2. The pipette-filling solution and the bath solution used for inside-out excised patch recordings contained (in mM): 140 KCl, 20 MOPS, 1 K2EGTA, pH 7.2. CaCl2 was added to adjust free [Ca2+]. Pipettes (2.5-5.0 MOmega in bath solution) were pulled from borosilicate glass, coated with SYLGARD, and fire-polished. Whole-cell currents were evoked by step depolarization of the membrane potential from -60 to 100 mV in 20 mV increments. Leakage currents, which were negligible, were uncorrected, and series resistance was compensated ~80%. Data were filtered at 2 or 5 kHz and digitized at 10 or 40 kHz. Ensemble averages of excised patch records were made by repetitively stepping (50-200 sweeps) the membrane potential of outside-out patches from -60 to 40 mV every 2 sec. Capacitance and leak compensation were made with amplifier controls. Records were filtered at 1-2 kHz and digitized at 10 kHz. The control free [Ca2+] was determined to be 0.79 µM; this and all free [Ca2+] were determined by a Fura-2 fluorometric assay in accord with the manufacturer's instructions (Molecular Probes, Eugene, OR). Average ensemble and whole-cell currents were best fit by a least-squares minimized, two-component exponential function of the form y = A1 × exp[-(t - t0)/tau 1] + A2 × exp[-(t - t0)/tau 2] + C, where A is the current amplitude, tau  is the time constant, and C is the asymptotic current value. In most cases, two-tailed t tests were used to determine statistical significance of the differences in time-to-peak, tau 1, and tau 2 values.

Blocker and opener pharmacology. All drug solutions were introduced into the bath by gravity flow. Iberiotoxin (IbTX) and charybdotoxin (ChTX) (Peptides International, Louisville, KY) were prepared as aqueous stocks and diluted in MBS before use; tetrandrine (Aldrich, Milwaukee, WI) was prepared as a stock solution in dimethylformamide or dimethylsulfoxide (DMSO) and likewise diluted in the appropriate solution just before use. For IbTX and ChTX experiments, maximal suppression was defined as the peak suppression observed in response to 100-250 nM IbTX or 250-500 nM ChTX. These concentrations were sufficient to block all of the expressed current. Blockers were applied for at least 10 min. Logistic fits of the concentration-response relationships and EC50 estimates were obtained with KaleidoGraph software (Abelbeck). The BK channel opener NS1619 (Olesen et al., 1994) was made in-house, dissolved in DMSO (20 mM stock), and diluted to final concentration just before use.

Protein kinase A modulation. The effects of exposure to the catalytic subunit of the cAMP-dependent protein kinase A (PKA) (Promega, Madison, WI) on inside-out patches containing either hSlo or hSlo + hSlobeta bathed with symmetrical 140 mM KCl solutions were measured by continuously monitoring steady-state changes in NPopen (NPopen = I/i; n = number of active channels; Popen is the open probability, I is the mean current, and i is the single-channel current amplitude; bin width 5 sec) before and during application of 60 nM PKA in the bath solution. The bath solution also contained 500 µM Mg2+-ATP throughout the experiment. The free [Ca2+] of the bathing solution was 4.52 µM. Holding voltage was adjusted so that some channel closures to baseline were observed in the control solution. Recordings were filtered at 1 kHz and digitized at 10 kHz.


RESULTS

beta subunit cloning

hSlobeta was cloned by reverse transcription of human tracheal tissue and amplification of the cDNA via PCR protocols; the design of the oligonucleotide primers was based on the reported bovine sequence (Knaus et al., 1994). The amplified human DNA fragment was then used as a probe to screen a human uterus cDNA library. This library was used because of the low abundance of beta  subunit message present in brain (our unpublished results). Numerous positive plaques were identified, and of the four clones carried through plaque isolation, all proved to be beta  subunit homologs with various amounts of 5' and 3' untranslated sequence. Alignment of the human and bovine protein sequences shows 85% identity (Fig. 1). The rat brain and smooth muscle beta  subunit sequences, which are highly homologous to the human and bovine sequences, were identical to each other (our unpublished results), and there is unlikely to be any difference between the human smooth muscle and human brain beta  subunit.
Fig. 1. Predicted primary sequence of a cloned human BK channel beta  subunit (hSlobeta ) and its alignment with a bovine beta  subunit. The identical amino acids are boxed together, resulting in 85% identity between these sequences with the putative M2 transmembrane domain being completely conserved. The putative transmembrane domains M1 and M2 are marked within the consensus sequence by the black boxes.
[View Larger Version of this Image (47K GIF file)]

Activation/relaxation and inactivation kinetics

In general, hSlo produced rapidly activating currents in response to depolarization, and partial slow inactivation was observed with long voltage pulses. Coexpression of hSlo and the hSlobeta subunit produced more slowly activating currents in which slow inactivation was greatly reduced (see below). Coexpression of hSlobeta with the voltage-dependent K+ channels KV1.3, KV1.4, and KV1.5 produced no detectable difference in activation, inactivation, or peak amplitude values of currents mediated by these channels (data not shown). Oocytes injected with hSlobeta alone did not produce any detectable current, and there was no noticeable alteration in the characteristics of the native oocyte current.

Although steady-state channel kinetics could not be studied because of the large number of channels in most excised patches, we could directly measure the activation kinetics of hSlo and hSlo + hSlobeta . Excised and whole-cell patch-clamp recordings from transiently transfected HEK 293 cells and two-electrode voltage-clamp recordings in oocytes demonstrated that activation of hSlo channels was fast, whereas activation of hSlo + hSlobeta channels was significantly slower (Fig. 2, Table 1; all values are mean ± SEM throughout). Current relaxation was similarly influenced by hSlobeta coexpression (Table 1). The difference in activation kinetics was maintained when examined at multiple voltage-step values (-60 mV to 60, 80, and 100 mV, whole-cell patch recording in HEK 293 cells). At 60, 80, and 100 mV, respectively (n = 5), hSlo current activation time constants were tau 1 = 1.57 ± 0.20 msec, 1.25 ± 0.18 msec, and 0.89 ± 0.10 msec, and tau 2 = 20.96 ± 5.59 msec, 16.13 ± 7.63 msec, and 10.22 ± 4.87 msec, whereas corresponding values for hSlo + hSlobeta (n = 5) were tau 1 = 10.22 ± 2.74 msec, 9.98 ± 2.12 msec, and 6.64 ± 1.39 msec, and tau 2 = 77.49 ± 24.20 msec, 84.91 ± 28.40 msec, and 56.10 ± 28.18 msec (repeated measures ANOVA; tau 1: F = 10.61, p < 0.0001; tau 2: F = 3.69, p = 0.016). In oocytes, a similar difference between the experimental groups was observed when time to peak current was measured at voltage steps from -60 mV (hold) to 60-140 mV in 20 mV increments (data for steps to 140 mV shown in Table 1; F = 72.4, p < 0.0001). Slow current inactivation was significantly reduced and slowed in oocytes and HEK 293 cells expressing hSlo + hS3lobeta (Figs. 2, 3), and hSlo currents in oocytes recovered from inactivation significantly more slowly (Fig. 3).


Fig. 2. Activation records for hSlo and hSlo + hSlobeta BK channels in oocytes and HEK 293 cells. Activation of hSlo + hSlobeta BK currents was significantly slower than currents mediated by hSlo expression in Xenopus oocytes (A) and HEK 293 cells (B; whole-cell patch recordings, C; ensemble average currents from excised membrane patches, D; excised patch recordings, single traces). Currents were normalized for presentation. Peak current values in A, 6.4 µA for hSlo and 4.6 µA for hSlo + hSlobeta ; currents shown are in response to a depolarizing step from -60 to 80 mV. In B, 17.1 nA for hSlo and 11.7 nA for hSlo + hSlobeta ; currents shown resulted from voltage steps from -60 to 100 mV. In C, 114 pA for hSlo and 355 pA for hSlo + hSlobeta . Horizontal axis scale: 20 msec for A and B, 40 msec for C. The currents in C and D resulted from voltage steps from -60 to 40 mV. The pulse duration for the multichannel recordings in D is 200 msec; note that the patches contain different (and large) numbers of channels; initial amplitude (i.) is 110 pA. No significant difference was observed in the amplitudes of hSlo or hSlo + hSlobeta currents in either expression system after comparable incubation periods; likewise, no difference was observed in the single-channel slope conductance of channels coded by these constructs when currents from patches with a small number of channels were recorded (hSlo = 286 ± 12 pS, n = 5; hSlo + hSlobeta  = 289 ± 6 pS, n = 4). Note that deactivation of hSlo + hSlobeta currents was also slower, as indicated in A and visible in C and D (see Table 1).
[View Larger Version of this Image (12K GIF file)]

Table 1. Activation and relaxation kinetics of hSlo and hSlo + hSlobeta


Expressed channel Activation (outside-out patch) Relaxation (inside-out patch) Time to peak current (outside-out patch) Time to peak current (two-electrode voltage clamp, oocytes)

hSlo  tau 1  = 1.17 msec ± 0.25  tau 1  = 2.57 msec ± 0.39 28.7 msec ± 5.8 11.76 msec ± 0.86
 tau 2  = 10.78 msec ± 3.02  tau 2  = 15.78 msec ± 4.35
n = 7 n = 5 n = 7 n = 5
hSlo + hSlobeta  tau 1  = 9.27 msec ± 0.83**  tau 1  = 4.01 msec ± 0.50* 145.6 msec ± 19.6* 24.24 msec ± 1.55**
 tau 2  = 48.89 msec ± 12.10**  tau 2  = 28.37 msec ± 9.14
n = 4 n = 4 n = 6 n = 5

Several methods were used to examine the relative activation rates of hSlo and hSlo + hSlobeta BK channels in HEK 293 cells and oocytes. Current activation and relaxation kinetics were best fit using a two-component exponential model of the form y = A1 × exp[- (t - to)/tau 1] + A2 × exp[- (t - to)/tau 2] + C (see text). Time to peak currents were directly measured. Values given for oocyte times to peak current are for a voltage step between -60 and 140 mV; details of all other recordings are given in the description of experimental procedures. All values are mean ± SEM. Comparisons are two-tailed t tests. hSlo + hSlobeta versus hSlo, *p < 0.05, **p < 0.005.


Fig. 3. Slow current inactivation reduction in oocytes expressing hSlo + hSlobeta relative to those expressing hSlo. A, In a paired-pulse paradigm, to examine the rate of recovery from inactivation, a 1 sec voltage step (-60 mV hold to 100 mV) was used as the ``conditioning'' stimulus to produce a significant level of inactivation (time 0, end of the conditioning pulse), followed at an increasing interval by a single identical ``test'' voltage step. Initial inactivation was measured by comparing the early peak current of the conditioning voltage step with the residual current at the end of the first step. Peak current amplitudes of the subsequent step in each paired episode were used to measure recovery. The conditioning step produced significantly greater levels of inactivation of hSlo currents compared with expressing hSlo + hSlobeta currents (t test; p < 0.001), and recovery was significantly slower (repeated measures ANOVA, F = 15.9, p = 0.005). Full recovery was not achieved by 7.5 sec after the conditioning pulse. With longer single voltage steps (10 sec), a significant increase in the time course of inactivation was observed (hSlo tau 1 = 309.7 ± 36.2 msec, n = 5; hSlo + hSlobeta tau 1 = 702.0 ± 88.2 msec, n = 5; p = 0.003, two-tailed t test; tau 2 values not reported because of contamination by slowly activating native current). B, Examples of current inactivation and its recovery resulting from the paired-pulse paradigm (8 sweeps) in oocytes expressing hSlo or hSlo + hSlobeta . The level of inactivation was independent of current amplitude (expression level) within the normal limits encountered in this study. There was no inactivation of native Ca2+-activated Cl- current, and currents represent IbTX-sensitive current components, after subtraction of residual currents in supramaximal IbTX.
[View Larger Version of this Image (16K GIF file)]

As reported previously, coexpression of mSlo and bSlobeta (bovine) resulted in a significant increase in the Ca2+ sensitivity of the expressed BK channels (McCobb et al., 1995; McManus et al., 1995). Similar results were obtained with hSlo and hSlobeta coexpression. This was observed as a leftward shift in the conductance/voltage (g/V) relationship (Fig. 4A) and a reduction in the half-maximal activation voltage for any tested Ca2+ concentration (Fig. 4B).


Fig. 4. Coexpression of hSlo + hSlobeta increased the sensitivity of BK channels to intracellular Ca2+. A, Conductance (g/gmax)/voltage (g/V) plots generated for hSlo (i.) and hSlo + hSlobeta (ii.) in 28.2 µM Ca2+ (a) and 0.79 µM Ca2+ (b); recordings obtained from inside-out excised patches from transiently transfected HEK 293 cells in response to voltage ramps (-100 to 100 mV, 4 sec duration; data from a minimum of 25 ramps per patch). Note that at both concentrations of intracellular Ca2+, the g/V relationship for hSlo + hSlobeta is shifted to the left, indicating increased Ca2+ sensitivity. Curves were generated with a standard Boltzmann relationship in which g/gmax = (1 +exp[(V1/2 - Vm)/K])-1. B, The half-maximal activation values (V1/2) for three concentrations of intracellular Ca2+ are plotted for hSlo and hSlo + hSlobeta ; V1/2 values were consistently lower (as plotted) for hSlo coexpressed with the hSlobeta subunit.
[View Larger Version of this Image (21K GIF file)]

Pharmacology of hSlo- and hSlo + hSlobeta -mediated currents

To determine whether differences existed in the pharmacology of hSlo- and hSlo + hSlobeta -mediated currents, we applied IbTX (Galvez et al., 1990; Giangiacomo et al., 1992) and ChTX (Miller et al., 1985; Sugg et al., 1990), which are high-affinity peptidyl blockers of the rat brain type I BK channel (Reinhart et al., 1989), and tetrandrine, an alkaloid blocker of the rat brain type II BK channel (Wang and Lemos, 1992), to oocytes and/or HEK 293 cells expressing these constructs. A marked difference in the sensitivity of the currents to both IbTX and tetrandrine was observed. The currents in oocytes expressing hSlo were significantly more sensitive to IbTX than those in oocytes expressing hSlo + hSlobeta (Fig. 5A; EC50 = 11.4 nM for hSlo, EC50 = 163.7 for hSlo + hSlobeta ). Less effect of coexpression was observed in the responses to ChTX; a small increase in sensitivity was noted in the oocytes expressing hSlo + hSlobeta (Fig. 5B), but these effects were not significant. The blockade by both peptides occurred more slowly in oocytes expressing hSlo + hSlobeta , although this was not quantified. Application of the alkaloid tetrandrine to HEK 293 cells expressing either hSlo or hSlo + hSlobeta revealed a concentration-dependent depression of BK current; however, the potency of blockade was much greater on hSlo + hSlobeta -mediated currents (Fig. 6A). In addition, tetrandrine was shown to exacerbate the slower activation kinetics of the hSlo + hSlobeta currents; this was particularly evident in the oocytes, in which tetrandrine produced a marked slowing of the current activation, with a significant increase in the latency to current peak (Fig. 6B). No consistent differences were observed in the concentration-response (1.0-100 µM) relationship of the benzimidazolone BK channel opener NS1619 (Olesen et al., 1994) between the two types of BK channels (Fig. 7). This was consistent with an earlier report that openers of this class, unlike DHS-1, did not distinguish between types of native BK channels (McKay et al., 1994).
Fig. 5. IBTX and ChTX pharmacology. A, Application of the BK channel-blocking peptide IbTX to oocytes expressing hSlo or hSlo + hSlobeta revealed that coexpression with the hSlobeta subunit resulted in a nearly 10-fold decrease in the sensitivity to IbTX blockade; n = 5-10 oocytes/IbTX concentration. Maximal effect was defined as the effect produced by incubation in 100-250 nM IbTX; maximal levels of suppression did not differ significantly between hSlo and hSlo + hSlobeta . B, Application of the peptidyl blocker ChTX did not reveal a significantly different profile of blockade for hSlo and hSlo + hSlobeta . Maximal effect was defined as the response to 250-500 nM ChTX, and maximal levels of effect did not differ between hSlo and hSlo + hSlobeta .
[View Larger Version of this Image (19K GIF file)]


Fig. 6. Tetrandrine pharmacology in oocytes and HEK 293 cells. A, Suppression of hSlo-mediated whole-cell membrane currents in HEK 293 cells by the alkaloid type II BK blocker tetrandrine was reduced relative to the degree of block observed in cells transfected with hSlo + hSlobeta ; n = 5-9 cells/tetrandrine concentration. The fitted curves suggest multiple affinity interactions of tetrandrine with both constructs; absolute maximal levels of tetrandrine block could not be determined because of limited solubility. The traces are examples of the relative effects of 2.5 µM tetrandrine on whole-cell HEK 293 BK membrane currents. Note that tetrandrine slowed activation of both types of current, but this effect was most pronounced with a greater level of block produced in cells expressing hSlo + hSlobeta . B, A pronounced increase in the latency to current peak was observed only in oocytes expressing hSlo and hSlo + hSlobeta when exposed to tetrandrine. Traces depict the effect of 50 µM tetrandrine (b.) on BK currents in oocytes expressing hSlo (top traces; i.), or hSlo + hSlobeta (bottom traces; ii.), relative to control values (a.). The dotted trace in the bottom set is the control hSlo trace for comparison. Tetrandrine had no effect on the current activation in the hSlo oocyte, but it significantly delayed the peak of the current in the oocyte expressing hSlo + hSlobeta (EC50 = 8.5 µM). The currents are the response to voltage steps from a holding potential of -60 to 100 mV, and only the initial portions of the normalized currents are depicted.
[View Larger Version of this Image (24K GIF file)]


Fig. 7. Effects of the application of the BK channel opener NS1619. At a range of NS1619 concentrations, oocytes injected with either hSlo or hSlo + hSlobeta cRNA showed similar levels of activation of whole-cell BK currents. Measured currents represent the response to a voltage step from -60 to 140 mV. A minimum of five oocytes were used for each concentration of NS1619.
[View Larger Version of this Image (17K GIF file)]

Modulation of hSlo- and hSlo + hSlobeta -mediated currents by PKA

BK channels are modulated by cAMP-dependent protein phosphorylation and dephosphorylation, with most type I channels increasing Popen in response to phosphorylation and most type II channels showing decreased activity when phosphorylated (Reinhart et al., 1989, 1991). The catalytic subunit of PKA was applied to the cytosolic side of hSlo and hSlo + hSlobeta channels in excised membrane patches from transfected HEK 293 cells. The hSlo channels (6 of 6) showed a marked and reversible increase in Popen after exposure to PKA, whereas the majority of hSlo + hSlobeta channels (5 of 8) showed a reduction in Popen (Fig. 8).
Fig. 8. Modulation of hSlo and hSlo + hSlobeta channels by exposure to PKA. A, Application of the catalytic subunit of PKA produced an increase in NPopen when applied to the cytosolic side of an inside-out membrane patch excised from an HEK 293 cell transiently expressing hSlo. B, PKA reduced NPopen in a patch excised from an HEK 293 cell transiently coexpressing hSlo + hSlobeta . The mean increase in NPopen (averaged over the entire 240 sec control period vs the 240 sec PKA application) for hSlo patches was 97.1 ± 35.9% (SEM all) above control values (n = 6; increases seen in all 6 patches); the mean decrease in NPopen recorded from hSlo + hSlobeta patches was -19.0 ± 15.6% (n = 8; 5 decreased, 1 no change, 2 increased, all data included in average; the difference was significant, p < 0.03, two-tailed t test). Partial recovery after removal of PKA was observed in some patches during a 240 sec wash period (data not shown).
[View Larger Version of this Image (22K GIF file)]


DISCUSSION

The slower activation of hSlo + hSlobeta currents is unlikely to result from the increased Ca2+ sensitivity of these channels in the presence of the hSlobeta subunit. A recent report (DiChiara and Reinhart, 1995) showed that increasing Ca2+ concentrations produced more rapid activation of dSlo and hSlo BK channels; assuming that increased Ca2+ sensitivity of hSlo in the presence of the hSlobeta subunit acted like an apparent increase in Ca2+ concentration relative to hSlo channels when all other variables were equivalent, a decrease in activation time would be expected, rather than the observed increase. Increasing the step voltage likewise was shown to reduce activation time for hSlo (DiChiara and Reinhart, 1995). Although this was observed for both constructs, the significant difference in activation time and time to peak current was independent of the step voltage. The increased time to deactivation of hSlo + hSlobeta , however, was consistent with an increase in Ca2+ sensitivity in the presence of the subunit (DiChiara and Reinhart, 1995), and we therefore cannot eliminate this as the cause of the slower deactivation/relaxation.

In some important respects, coexpression produced BK channels and currents consistent with Type II BK channel characteristics, whereas hSlo channels had some characteristics consistent with a Type I classification. The hSlo channels had greater sensitivity to IbTX, faster activation kinetics, and channel activity was upregulated by PKA, which are type I characteristics. The hSlo + hSlobeta channels, on the other hand, were less sensitive to IbTX, had much slower activation kinetics, and were downregulated by PKA application, which are type II characteristics (Reinhart et al., 1989, 1991). The relatively greater effect of tetrandrine on hSlo + hSlobeta currents was also phenotypically similar to type II BK channels. In a previous study, coexpression of a bovine beta  subunit (bSlobeta ) and a mouse Slo homolog (mSlo) resulted in an increase in Ca2+ sensitivity (McManus et al., 1995), which we likewise observed with coexpression of hSlo and hSlobeta . Although they reported that coexpression resulted in the disappearance of brief closed events, they did not report detailed changes in channel kinetics or differences in sensitivity to toxin blockade. This may be the result of the constructs expressed; although mammalian Slo proteins are highly homologous (e.g., mSlo vs hSlo, 98% sequence identity; Dworetzky et al., 1994), it seems that Slobeta subunit sequences do not have the same degree of identity (Fig. 1), and these differences may be sufficient to affect expression and/or function. In at least two characteristics, however, we found variance with the original characterization of type I and type II channels. Type I channels were found to be somewhat more sensitive to [Ca2+]in (Reinhart et al., 1989), which would be inconsistent with hSlo being the type I BK channel, based on our data and that of the previous study. In addition, the similar levels of block by ChTX suggests that this classification is not applicable to all of the BK channel phenotypic alterations produced by Slobeta subunit coexpression. However, we must also keep in mind that the original classification resulted from the characterization of rat brain BK channels, and differences with the human (hSlo) phenotype could underlie the observed variance.

Although we observed protein expression of hSlo and hSlobeta separately in HEK 293 cells (data not shown), we have not demonstrated coexpression of both proteins within the same cell independent of electrophysiological recordings. Therefore, we could not eliminate recordings in which coexpression did not seem to be successful. This had the result of making the effects of coexpression seem more variable (note increased SEM values for most measures in cells expressing hSlo + hSlobeta ) and may have been a particular problem in the PKA experiments, in which the consequence of coexpression was a change in direction of modulation rather than in degree of effect. Nevertheless, these results indicate that in some important characteristics hSlo resembled the rat brain type I BK channel, whereas coexpression of the hSlobeta subunit altered some characteristics of the expressed hSlo channel phenotype to a type II profile.

It was difficult to directly compare the quantitative measurements of our cloned expressed BK channels with those reported for native type I and type II BK channels. In particular, relatively few studies have focused on native populations of type I and type II BK channels, and experiments in these cases were generally performed in different systems and under different experimental conditions. Nevertheless, in the PKA experiments, we observed close to a doubling of Popen when hSlo channels were exposed to PKA, which is very similar to the values reported for the type I channel recorded from lipid bilayers (Reinhart et al., 1991). In the hSlo + hSlobeta experiments, when PKA was applied to these channels, a small but significant decrease in Popen was observed that was not as large as the downregulation for the type II channels recorded in lipid bilayers. However, given that two of the patch recordings showed an increase after exposure to PKA, the results suggest the presence of a mixed population of channels, at least with respect to their response to phosphorylation, which may reflect the presence of both hSlo channels with and without coexpression of hSlobeta despite cotransfection. If the channels in which PKA did not produce an upregulation of Popen are considered alone, the PKA-induced decrease in Popen in patches from hSlo + hSlobeta -transfected cells would then closely resemble the comparable reduction for native type II channels (Reinhart et al., 1991). In addition, estimated EC50 values for hSlo-expressing cells for BK channel blockers are within an order of magnitude of values similarly obtained for native (toxin-sensitive and presumably type I) BK channels (Reinhart et al., 1989; Giangiacomo et al., 1992). However, the hSlo + hSlobeta toxin curves in Figures 5 and 6 seem to be shallow compared with hSlo alone and do not reflect the degree of insensitivity expected of a pure population of type II BK channels. The shallow curves may suggest the presence of two binding sites, again suggestive of a mixed population of channels, at least in the oocytes. Regardless of the exact degree or correspondence between cloned hSlo and hSlo + hSlobeta BK channels and any previously described BK channel classification scheme, it is clear from the data presented in this study that the association of the BK-specific hSlobeta subunit confers significant phenotypic alteration to hSlo channels. Thus, the hSlobeta subunit is a likely major source of observed phenotypic variation in native BK channel populations, but is not the only source of BK channel diversity.

In conclusion, the changes in phenotype produced by this single known Slobeta subunit are significant and are manifest in several modalities. When coupled with changes produced by alternative splice variation, the contribution of the hSlobeta subunit forms part of the molecular basis for native BK channel diversity. A better understanding of the interactions of these channels and their regulatory subunit(s) should provide insight into the structural determinants of BK channel modulation and its functional consequences on cellular physiology.

Note added in proof: Subsequent to the submission of this manuscript, Meera et al. (1996) report that coexpression of hSlo and hSlobeta produced an increase in current activation time constants and an increase in Ca2+ sensitivity.


FOOTNOTES

Received March 7, 1996; revised May 3, 1996; accepted May 7, 1996.

  

Correspondence should be addressed to Dr. Valentin K. Gribkoff, Central Nervous System Drug Discovery, Department 404, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492.



REFERENCES

  • Adelman JP, Shen K-Z, Kavanaugh MP, Warren RA, Wu Y-N, Lagrutta A, Bond CT, North RA (1992) Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron 9:206-216.
  • Atkinson NS, Robertson GA, Ganetzky B (1991) A component of calcium-activated potassium channels encoded by the Drosophila slo locus. Science 253:551-553 . [Abstract/Free Full Text]
  • Bielefeldt K, Jackson M (1993) A calcium-activated potassium channel causes frequency-dependent action-potential failures in a mammalian nerve terminal. J Neurophysiol 70:284-298 . [Abstract/Free Full Text]
  • Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L (1993) mSlo, a complex mouse gene encoding ``maxi'' calcium-activated potassium channels. Science 261:221-224 . [Abstract/Free Full Text]
  • Chandy KG, Gutman GA (1995) Voltage-gated potassium channel genes. In: Handbook of receptors and channels: ligand- and voltage-gated ion channels (North, RA, eds) , p. 1. Boca Raton, FL: CRC.
  • Colman A (1984) Translation of eukaryotic messenger RNA in Xenopus oocytes. In: Transcription and translation: a practical approach. (Hames, BD, Higgins, SJ, eds) , p. 271. Oxford: IRC.
  • DiChiara TJ, Reinhart PH (1995) Distinct effects of Ca2+ and voltage on the activation and deactivation of cloned Ca2+-activated K+ channels. J Physiol (Lond) 489:403-418. [Abstract/Free Full Text]
  • Dworetzky SI, Trojnacki JT, Gribkoff VK (1994) Cloning and expression of a human large-conductance calcium-activated potassium channel. Mol Brain Res 27:189-193 . [Medline]
  • Galvez A, Giminez-Gallago G, Reuben JP, Roy-Constancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265:11083-11090 . [Abstract/Free Full Text]
  • Giangiacomo KM, Garcia ML, McManus OB (1992) Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 31:6719-6727 . [Medline]
  • Hamill OP, Marty O, Neher E, Sakman B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflügers Arch 391:85-100 . [Web of Science][Medline]
  • Knaus H-G, Folander K, Garcia-Calvo M, Garcia ML, Kaczorowski G, Smith M, Swanson R (1994) Primary sequence and immunological characterization of beta -subunit of high conductance Ca2+-activated K+ channel from smooth muscle. J Biol Chem 269:17274-17278 . [Abstract/Free Full Text]
  • Kozak M (1987) An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148 . [Abstract/Free Full Text]
  • Lagrutta A, Shen K-Z, North RA, Adelman JP (1994) Functional differences among alternatively spliced variants of slowpoke, a Drosophila calcium-activated potassium channel. J Biol Chem 269:20347-20351 . [Abstract/Free Full Text]
  • Latorre R, Oberhauser A, Labarca P, Alvarez O (1989) Varieties of calcium-activated potassium channels. Annu Rev Physiol 51:385-399 . [Web of Science][Medline]
  • McCobb DP, Fowler NL, Featherstone T, Lingle CJ, Saito M, Krause JE, Salkoff L (1995) Am J Physiol 38:H767-H777.
  • McKay MC, Dworetzky SI, Meanwell NA, Olesen S-P, Reinhart PH, Levitan IB, Adelman JP, Gribkoff VK (1994) Opening of large-conductance calcium-activated potassium channels by the substituted benzimidazolone NS004. J Neurophysiol 71:1873-1882 . [Abstract/Free Full Text]
  • McManus OB, Helms LMH, Pallanck L, Ganetzky B, Swanson R, Leonard RJ (1995) Functional role of the beta  subunit of high conductance calcium-activated potassium channels. Neuron 14:645-650 . [Web of Science][Medline]
  • Meera P, Wallner M, Jiang Z, Toro L (1996) A calcium switch for the functional coupling between alpha  (hSlo) and beta  subunits (KV, Cabeta ) of maxi K channels. FEBS Lett 382:84-88 . [Web of Science][Medline]
  • Miller C, Moczydlowski E, Latorre R, Phillips M (1985) Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature 313:316-318 . [Medline]
  • Olesen S-P, Munch E, Moldt P, Drejer J (1994) Selective activation of Ca2+-dependent K+ channels by novel benzimidazolone. Eur J Pharmacol 251:53-57 . [Web of Science][Medline]
  • Pallanck L, Ganetzky B (1994) Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. Hum Mol Genet 3:1239-1243 . [Abstract/Free Full Text]
  • Pongs O (1992) Molecular biology of voltage-dependent potassium channels. Physiol Rev [Suppl] 72:S69-S88.
  • Reinhart PH, Chung S, Levitan IB (1989) A family of calcium-dependent potassium channels from rat brain. Neuron 2:1031-1041 . [Web of Science][Medline]
  • Reinhart PH, Chung S, Martin BL, Brautigan DL, Levitan IB (1991) Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A. J Neurosci 11:1627-1635 . [Abstract]
  • Rettig J, Heinemann SH, Wunder F, Lorra C, Parcej DN, Dolly JO, Pongs O (1994) Inactivation properties of voltage-gated K+ channels altered by presence of beta -subunit. Nature 369:289-294 . [Medline]
  • Robitaille R, Charlton MP (1992) Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci 21:297-303.
  • Salkoff L, Baker K, Butler A, Covarrubias M, Pak MD, Wei A (1992) An essential ``set'' of K+ channels conserved in flies, mice, and humans. Trends Neurosci 15:161-166 . [Web of Science][Medline]
  • Stuhmer W (1992) Electrophysiology recording from Xenopus oocytes. In: Methods in enzymology: ion channels, (Rudy, B, Iverson, LE, eds) , Vol 207, p. 319. San Diego, CA: Academic.
  • Sugg EE, Garcia ML, Reuben JP, Patchett AA, Kaczorowski G (1990) Synthesis and structural characterization of charybdotoxin, a potent peptidyl inhibitor of the high-conductance Ca2+-activated K+ channel. J Biol Chem 265:18745-18748 . [Abstract/Free Full Text]
  • Tseng-Crank J, Foster CD, Krause JD, Mertz R, Godinot N, DeChiara TJ, Reinhart PH (1994) Cloning, expression, and distribution of functionally distinct Ca2+-activated K+ channel isoforms from human brain. Neuron 13:1315-1330 . [Web of Science][Medline]
  • Wang G, Lemos JR (1992) Tetrandrine blocks a slow, large-conductance Ca2+-activated potassium channel besides inhibiting a non-inactivating Ca2+ current in isolated terminal of the rat neurohypophysis. Pflügers Arch 421:558-565 . [Web of Science][Medline]

Copyright ©1996 Society for Neuroscience   0270-6474/1996/164543-8$05.00/0



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Liu, Y. Wei, P. Sun, W.-H. Wang, T. R. Kleyman, and L. M. Satlin
Mechanoregulation of BK channel activity in the mammalian cortical collecting duct: role of protein kinases A and C
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F904 - F915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Perry and G. I. Sandle
Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G159 - G167.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. M. Wynne, S. I. Puig, G. E. Martin, and S. N. Treistman
Compartmentalized {beta} Subunit Distribution Determines Characteristics and Ethanol Sensitivity of Somatic, Dendritic, and Terminal Large-Conductance Calcium-Activated Potassium Channels in the Rat Central Nervous System
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 978 - 986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tian, H. McClafferty, L. Chen, and M. J. Shipston
Reversible Tyrosine Protein Phosphorylation Regulates Large Conductance Voltage- and Calcium-activated Potassium Channels via Cortactin
J. Biol. Chem., February 8, 2008; 283(6): 3067 - 3076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Lv, M. Chen, G. Gan, L. Wang, T. Xu, and J. Ding
Four-turn {alpha}-Helical Segment Prevents Surface Expression of the Auxiliary h{beta}2 Subunit of BK-type Channel
J. Biol. Chem., February 1, 2008; 283(5): 2709 - 2715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Liu, T. Morimoto, C. Woda, T. R. Kleyman, and L. M. Satlin
Ca2+ dependence of flow-stimulated K secretion in the mammalian cortical collecting duct
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F227 - F235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. R. Grimm, R. M. Foutz, R. Brenner, and S. C. Sansom
Identification and localization of BK-beta subunits in the distal nephron of the mouse kidney
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F350 - F359.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. K. McGahon, D. P. Dash, A. Arora, N. Wall, J. Dawicki, D. A. Simpson, C. N. Scholfield, J. G. McGeown, and T. M. Curtis
Diabetes Downregulates Large-Conductance Ca2+-Activated Potassium {beta}1 Channel Subunit in Retinal Arteriolar Smooth Muscle
Circ. Res., March 16, 2007; 100(5): 703 - 711.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
B. Wang and R. Brenner
An S6 Mutation in BK Channels Reveals {beta}1 Subunit Effects on Intrinsic and Voltage-dependent Gating
J. Gen. Physiol., December 1, 2006; 128(6): 731 - 744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Satlin, M. D. Carattino, W. Liu, and T. R. Kleyman
Regulation of cation transport in the distal nephron by mechanical forces
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F923 - F931.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Semenov, B. Wang, J. T. Herlihy, and R. Brenner
BK channel beta1-subunit regulation of calcium handling and constriction in tracheal smooth muscle
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L802 - L810.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Diez-Sampedro, W. R. Silverman, J. F. Bautista, and G. B. Richerson
Mechanism of Increased Open Probability by a Mutation of the BK Channel
J Neurophysiol, September 1, 2006; 96(3): 1507 - 1516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. L. Pluznick and S. C. Sansom
BK channels in the kidney: role in K+ secretion and localization of molecular components
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F517 - F529.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. T. King, P. V. Lovell, M. Rishniw, M. I. Kotlikoff, M. L. Zeeman, and D. P. McCobb
beta2 and beta4 Subunits of BK Channels Confer Differential Sensitivity to Acute Modulation by Steroid Hormones
J Neurophysiol, May 1, 2006; 95(5): 2878 - 2888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Resnik, J. Herron, R. Fu, D. D. Ivy, and D. N. Cornfield
Oxygen tension modulates the expression of pulmonary vascular BKCa channel {alpha}- and beta-subunits
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L761 - L768.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
J. Thompson and T. Begenisich
Membrane-delimited Inhibition of Maxi-K Channel Activity by the Intermediate Conductance Ca2+-activated K Channel
J. Gen. Physiol., January 30, 2006; 127(2): 159 - 169.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
P. Orio, Y. Torres, P. Rojas, I. Carvacho, M. L. Garcia, L. Toro, M. A. Valverde, and R. Latorre
Structural Determinants for Functional Coupling Between the {beta} and {alpha} Subunits in the Ca2+-activated K+ (BK) Channel
J. Gen. Physiol., January 30, 2006; 127(2): 191 - 204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi
Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Najjar, H. Zhou, T. Morimoto, J. B. Bruns, H.-S. Li, W. Liu, T. R. Kleyman, and L. M. Satlin
Dietary K+ regulates apical membrane expression of maxi-K channels in rabbit cortical collecting duct
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F922 - F932.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. I. Zakharov, J. P. Morrow, G. Liu, L. Yang, and S. O. Marx
Activation of the BK (SLO1) Potassium Channel by Mallotoxin
J. Biol. Chem., September 2, 2005; 280(35): 30882 - 30887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Perez
Dual Effect of Tamoxifen on Arterial KCa Channels Does Not Depend on the Presence of the {beta}1 Subunit
J. Biol. Chem., June 10, 2005; 280(23): 21739 - 21747.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
P. Orio and R. Latorre
Differential Effects of {beta}1 and {beta}2 Subunits on BK Channel Activity
J. Gen. Physiol., March 28, 2005; 125(4): 395 - 411.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H.-H. Lim and C.-S. Park
Identification and Functional Characterization of Ankyrin-Repeat Family Protein ANKRA as a Protein Interacting with BKCa Channel
Mol. Biol. Cell, March 1, 2005; 16(3): 1013 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. C. Hebert, G. Desir, G. Giebisch, and W. Wang
Molecular Diversity and Regulation of Renal Potassium Channels
Physiol Rev, January 1, 2005; 85(1): 319 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Nishimaru, M. Eghbali, R. Lu, J. Marijic, E. Stefani, and L. Toro
Functional and molecular evidence of MaxiK channel {beta}1 subunit decrease with coronary artery ageing in the rat
J. Physiol., September 15, 2004; 559(3): 849 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
W. Marcotti, S. L. Johnson, and C. J. Kros
Effects of intracellular stores and extracellular Ca2+ on Ca2+-activated K+ currents in mature mouse inner hair cells
J. Physiol., June 1, 2004; 557(2): 613 - 633.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Hu, M. Z. Labuda, M. Pandolfo, G. G. Goss, H. E. McDermid, and D. W. Ali
Variants of the KCNMB3 regulatory subunit of maxi BK channels affect channel inactivation
Physiol Genomics, November 11, 2003; 15(3): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. M. Hagen, O. Bayguinov, and K. M. Sanders
{beta}1-Subunits are required for regulation of coupling between Ca2+ transients and Ca2+-activated K+ (BK) channels by protein kinase C
Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1270 - C1280.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. A Widmer, I. C M Rowe, and M. J Shipston
Conditional protein phosphorylation regulates BK channel activity in rat cerebellar Purkinje neurons
J. Physiol., October 15, 2003; 552(2): 379 - 391.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Kim, J. Chung, E. Kim, and J. Han
Changes in the Ca2+-Activated K+ Channels of the Coronary Artery During Left Ventricular Hypertrophy
Circ. Res., September 19, 2003; 93(6): 541 - 547.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
E. S. L. Faber and P. Sah
Calcium-Activated Potassium Channels: Multiple Contributions to Neuronal Function
Neuroscientist, June 1, 2003; 9(3): 181 - 194.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
B. Matharoo-Ball, M.L.J. Ashford, S. Arulkumaran, and R.N. Khan
Down-Regulation of the {alpha}- and {beta}-Subunits of the Calcium-Activated Potassium Channel in Human Myometrium with Parturition
Biol Reprod, June 1, 2003; 68(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. D. Traub, E. H. Buhl, T. Gloveli, and M. A. Whittington
Fast Rhythmic Bursting Can Be Induced in Layer 2/3 Cortical Neurons by Enhancing Persistent Na+ Conductance or by Blocking BK Channels
J Neurophysiol, February 1, 2003; 89(2): 909 - 921.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Nehrke, C. C. Quinn, and T. Begenisich
Molecular identification of Ca2+-activated K+ channels in parotid acinar cells
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C535 - C546.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
X. Qian, C. M. Nimigean, X. Niu, B. L. Moss, and K. L. Magleby
Slo1 Tail Domains, but Not the Ca2+ Bowl, Are Required for the {beta}1 Subunit to Increase the Apparent Ca2+ Sensitivity of BK Channels
J. Gen. Physiol., November 25, 2002; 120(6): 829 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jin, T. M. Weiger, and I. B. Levitan
Reciprocal Modulation between the alpha and beta 4 Subunits of hSlo Calcium-dependent Potassium Channels
J. Biol. Chem., November 8, 2002; 277(46): 43724 - 43729.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jin, T. M. Weiger, Y. Wu, and I. B. Levitan
Phosphorylation-dependent Functional Coupling of hSlo Calcium-dependent Potassium Channel and Its hbeta 4 Subunit
J. Biol. Chem., March 15, 2002; 277(12): 10014 - 10020.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. S. L. Faber and P. Sah
Physiological Role of Calcium-Activated Potassium Currents in the Rat Lateral Amygdala
J. Neurosci., March 1, 2002; 22(5): 1618 - 1628.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Martin-Caraballo and S. E. Dryer
Activity- and Target-Dependent Regulation of Large-Conductance Ca2+-Activated K+ Channels in Developing Chick Lumbar Motoneurons
J. Neurosci., January 1, 2002; 22(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Van Goor, Y.-X. Li, and S. S. Stojilkovic
Paradoxical Role of Large-Conductance Calcium-Activated K+ (BK) Channels in Controlling Action Potential-Driven Ca2+ Entry in Anterior Pituitary Cells
J. Neurosci., August 15, 2001; 21(16): 5902 - 5915.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. V. Lovell and D. P. McCobb
Pituitary Control of BK Potassium Channel Function and Intrinsic Firing Properties of Adrenal Chromaffin Cells
J. Neurosci., May 15, 2001; 21(10): 3429 - 3442.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Marijic, Q. Li, M. Song, K. Nishimaru, E. Stefani, and L. Toro
Decreased Expression of Voltage- and Ca2+-Activated K+ Channels in Coronary Smooth Muscle During Aging
Circ. Res., February 2, 2001; 88(2): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. B. Ransom and H. Sontheimer
BK Channels in Human Glioma Cells
J Neurophysiol, February 1, 2001; 85(2): 790 - 803.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Pluger, J. Faulhaber, M. Furstenau, M. Lohn, R. Waldschutz, M. Gollasch, H. Haller, F. C. Luft, H. Ehmke, and O. Pongs
Mice With Disrupted BK Channel {beta}1 Subunit Gene Feature Abnormal Ca2+ Spark/STOC Coupling and Elevated Blood Pressure
Circ. Res., November 24, 2000; 87 (11): e53 - e60.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D.H. Cox and R.W. Aldrich
Role of the {beta}1 Subunit in Large-Conductance Ca2+-Activated K+ Channel Gating Energetics: Mechanisms of Enhanced Ca2+ Sensitivity
J. Gen. Physiol., September 1, 2000; 116(3): 411 - 432.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-M. Xia, J.-P. Ding, X.-H. Zeng, K.-L. Duan, and C. J. Lingle
Rectification and Rapid Activation at Low Ca2+ of Ca2+-Activated, Voltage-Dependent BK Currents: Consequences of Rapid Inactivation by a Novel beta Subunit
J. Neurosci., July 1, 2000; 20(13): 4890 - 4903.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. V. Lovell, D. G. James, and D. P. McCobb
Bovine Versus Rat Adrenal Chromaffin Cells: Big Differences in BK Potassium Channel Properties
J Neurophysiol, June 1, 2000; 83(6): 3277 - 3286.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
C. M. Nimigean and K. L. Magleby
Functional Coupling of the {beta}1 Subunit to the Large Conductance Ca2+-Activated K+ Channel in the Absence of Ca2+: Increased Ca2+ Sensitivity from a Ca2+-Independent Mechanism
J. Gen. Physiol., June 1, 2000; 115(6): 719 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. M. Weiger, M. H. Holmqvist, I. B. Levitan, F. T. Clark, S. Sprague, W.-J. Huang, P. Ge, C. Wang, D. Lawson, M. E. Jurman, et al.
A Novel Nervous System beta Subunit that Downregulates Human Large Conductance Calcium-Dependent Potassium Channels
J. Neurosci., May 15, 2000; 20(10): 3563 - 3570.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. PAPASSOTIRIOU, R. KÖHLER, J. PRENEN, H. KRAUSE, M. AKBAR, J. EGGERMONT, M. PAUL, A. DISTLER, B. NILIUS, and J. HOYER
Endothelial K+ channel lacks the Ca2+ sensitivity-regulating {beta} subunit
FASEB J, May 1, 2000; 14(7): 885 - 894.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
K. Ramanathan, T. H. Michael, and P. A. Fuchs
beta Subunits Modulate Alternatively Spliced, Large Conductance, Calcium-Activated Potassium Channels of Avian Hair Cells
J. Neurosci., March 1, 2000; 20(5): 1675 - 1684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Brenner, T. J. Jegla, A. Wickenden, Y. Liu, and R. W. Aldrich
Cloning and Functional Characterization of Novel Large Conductance Calcium-activated Potassium Channel beta Subunits, hKCNMB3 and hKCNMB4
J. Biol. Chem., February 25, 2000; 275(9): 6453 - 6461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Hall and D. L. Armstrong
Conditional and Unconditional Inhibition of Calcium-activated Potassium Channels by Reversible Protein Phosphorylation
J. Biol. Chem., February 11, 2000; 275(6): 3749 - 3754.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-N. Wu, H.-F. Li, and Y.-C. Lo
Characterization of Tetrandrine-Induced Inhibition of Large-Conductance Calcium-Activated Potassium Channels in a Human Endothelial Cell Line (HUV-EC-C)
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 188 - 195.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
M. J. Shipston, R. R. Duncan, A. G. Clark, F. A. Antoni, and L. Tian
Molecular Components of Large Conductance Calcium-Activated Potassium (BK) Channels in Mouse Pituitary Corticotropes
Mol. Endocrinol., October 1, 1999; 13(10): 1728 - 1737.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
E M C Jones, M Gray-Keller, and R Fettiplace
The role of Ca2+-activated K+ channel spliced variants in the tonotopic organization of the turtle cochlea
J. Physiol., August 1, 1999; 518(3): 653 - 665.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
B. S. Rothberg and K. L. Magleby
Gating Kinetics of Single Large-Conductance Ca2+-Activated K+ Channels in High Ca2+ Suggest a Two-Tiered Allosteric Gating Mechanism
J. Gen. Physiol., July 1, 1999; 114(1): 93 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-M. Xia, J. P. Ding, and C. J. Lingle
Molecular Basis for the Inactivation of Ca2+- and Voltage-Dependent BK Channels in Adrenal Chromaffin Cells and Rat Insulinoma Tumor Cells
J. Neurosci., July 1, 1999; 19(13): 5255 - 5264.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. G Clark, S. K Hall, and M. J Shipston
ATP inhibition of a mouse brain large-conductance K+ (mslo) channel variant by a mechanism independent of protein phosphorylation
J. Physiol., April 1, 1999; 516(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A R Evans, M R Vasko, and G D Nicol
The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones
J. Physiol., April 1, 1999; 516(1): 163 - 178.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
C. M. Nimigean and K. L. Magleby
The {beta} Subunit Increases the Ca2+ Sensitivity of Large Conductance Ca2+-activated Potassium Channels by Retaining the Gating in the Bursting States
J. Gen. Physiol., March 1, 1999; 113(3): 425 - 440.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K. Ramanathan, T. H. Michael, G. Jiang, H. Hiel, and P. A. Fuchs
A Molecular Mechanism for Electrical Tuning of Cochlear Hair Cells
Science, January 8, 1999; 283(5399): 215 - 217.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES
Pharmacology of CFTR Chloride Channel Activity
Physiol Rev, January 1, 1999; 79(1): 109 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Alioua, Y. Tanaka, M. Wallner, F. Hofmann, P. Ruth, P. Meera, and L. Toro
The Large Conductance, Voltage-dependent, and Calcium-sensitive K+ Channel, Hslo, Is a Target of cGMP-dependent Protein Kinase Phosphorylation in Vivo
J. Biol. Chem., December 4, 1998; 273(49): 32950 - 32956.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
K. M. Giangiacomo, A. Kamassah, G. Harris, and O. B. McManus
Mechanism of Maxi-K Channel Activation by Dehydrosoyasaponin-I
J. Gen. Physiol., October 1, 1998; 112(4): 485 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hanner, R. Vianna-Jorge, A. Kamassah, W. A. Schmalhofer, H.-G. Knaus, G. J. Kaczorowski, and M. L. Garcia
The beta  Subunit of the High Conductance Calcium-activated Potassium Channel. IDENTIFICATION OF RESIDUES INVOLVED IN CHARYBDOTOXIN BINDING
J. Biol. Chem., June 26, 1998; 273(26): 16289 - 16296.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
B. S. Rothberg and K. L. Magleby
Kinetic Structure of Large-Conductance Ca2+-activated K+ Channels Suggests that the Gating Includes Transitions through Intermediate or Secondary States: A Mechanism for Flickers
J. Gen. Physiol., June 1, 1998; 111(6): 751 - 780.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-m. Xia, B. Hirschberg, S. Smolik, M. Forte, and J. P. Adelman
dSLo Interacting Protein 1, a Novel Protein That Interacts with Large-Conductance Calcium-Activated Potassium Channels
J. Neurosci., April 1, 1998; 18(7): 2360 - 2369.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. A. Sullivan, M. H. Holmqvist, and I. B. Levitan
Characterization of Gating and Peptide Block of mSlo, a Cloned Calcium-Dependent Potassium Channel
J Neurophysiol, December 1, 1997; 78(6): 2937 - 2950.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D.H. Cox, J. Cui, and R.W. Aldrich
Allosteric Gating of a Large Conductance Ca-activated K+ Channel
J. Gen. Physiol., September 1, 1997; 110(3): 257 - 281.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hanner, W. A. Schmalhofer, P. Munujos, H.-G. Knaus, G. J. Kaczorowski, and M. L. Garcia
The beta  subunit of the high-conductance calcium-activated potassium channel contributes to the high-affinity receptor for charybdotoxin
PNAS, April 1, 1997; 94(7): 2853 - 2858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tian, R. R. Duncan, M. S. L. Hammond, L. S. Coghill, H. Wen, R. Rusinova, A. G. Clark, I. B. Levitan, and M. J. Shipston
Alternative Splicing Switches Potassium Channel Sensitivity to Protein Phosphorylation
J. Biol. Chem., March 9, 2001; 276(11): 7717 - 7720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Gerlach, C. A. Syme, L. Giltinan, J. P. Adelman, and D. C. Devor
ATP-dependent Activation of the Intermediate Conductance, Ca2+-activated K+ Channel, hIK1, Is Conferred by a C-terminal Domain
J. Biol. Chem., March 30, 2001; 276(14): 10963 - 10970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Zarei, N. Zhu, A. Alioua, M. Eghbali, E. Stefani, and L. Toro
A Novel MaxiK Splice Variant Exhibits Dominant-negative Properties for Surface Expression
J. Biol. Chem., May 4, 2001; 276(19): 16232 - 16239.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Meera, M. Wallner, and L. Toro
A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin
PNAS, May 9, 2000; 97(10): 5562 - 5567.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (145)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dworetzky, S. I.
Right arrow Articles by Gribkoff, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dworetzky, S. I.
Right arrow Articles by Gribkoff, V. K.

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-